Prognostic Value of Phosphatidylinositol-3 Kinase p110 α Protein Expression in Patients with Stage I–III Invasive Breast Cancer
p110α protein expression is an independent biomarker for adverse outcomes in stage I-III invasive breast cancer. Its assessment could improve prognostic evaluation and guide personalized therapy.
Authors
- Zhiqiang Zong
- F Li
- Xuan Zhou (ORCID: https://orcid.org/0000-0003-2044-1818)
- Min Yan (ORCID: https://orcid.org/0000-0002-9178-5565)
- Jian Shen (ORCID: https://orcid.org/0000-0001-7518-1473)
- Xian Wang
- Xi Xia
- Jingjing Li
Institutions
- Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Cancers
- Published
- 2026-01-19
- DOI
- https://doi.org/10.3390/cancers18020301
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Anhui Medical University